Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-03-26
1989-03-07
Springer, David B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548542, A61K 3140, C07D20748
Patent
active
048107220
ABSTRACT:
The therapeutic compounds useful in the treatment of patients suffering from intellectual or nervous asthenias, memory failures or old age and excessive intellectual fatigue having the formula (I): ##STR1## in which R.sub.1 represents an alkyl radical, linear or branched, containing up to 8 carbons atoms, an acyl radical containing from 1 to 6 carbon atoms or a cycloalkyl radical containing from 3 to 6 carbon atoms and R represents an aryl radical containing up to 14 carbon atoms, unsubstituted or substituted, or a mono- or polycyclic heterocyclic radical, unsubstituted or substituted. Also, therapeutic compositions containing the compound, method of preparing the compound and method of use.
REFERENCES:
patent: 3423426 (1969-01-01), Kuhn
patent: 3686169 (1972-08-01), Coran et al.
Drugs of the Future, vol. 10, No. 12, 1985, pp. 972, 974.
Barzaghi Fernando
Galliani Giulio
Toja Emilio
Zirotti Carlo
Roussel Uclaf
Springer David B.
LandOfFree
1-styrenesulphonyl-2-oxo-5-hydroxy pyrrolidines and their use fo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1-styrenesulphonyl-2-oxo-5-hydroxy pyrrolidines and their use fo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-styrenesulphonyl-2-oxo-5-hydroxy pyrrolidines and their use fo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1669098